84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size to Hit Around USD 2,517 Mn by 2032
March 27, 2023 02:27 ET | Market.Us
New York, March 27, 2023 (GLOBE NEWSWIRE) -- The global alpha-1 antitrypsin deficiency augmentation therapy market size accounted for USD 1,413 million in 2022 and growth is estimated to accelerate...
AATD-AUGMENTATION-THERAPY
Alpha-1 Antitrypsin Deficiency (AATD) Augmentation Therapy Market to Reach US$ 1959.8 Mn by 2026, Favoured by Grifols’ Worldwide Promotion for AlfaCare, Says Fortune Business Insights
July 12, 2019 03:11 ET | Fortune Business Insights
Pune, July 12, 2019 (GLOBE NEWSWIRE) -- The global alpha-1 antitrypsin deficiency (AATD) augmentation therapy market has been boosted by recent FDA approval for Prolastin-C. According to a report...